Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats-Reference-Cited by-同舟云学术

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats

Published:2022-06 Issue:6 Volume:30 Page:863-873
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Ahmed Sanaa,El-Sayed Mahmoud M.,Kandeil Mohamed A.,Khalaf Marwa M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference78 articles.

1. Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB/Nrf-2/PPAR-γ interplay in mice;Abdelhamid;Life Sci.,2020

2. Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NF κB and Nrf2-antioxidant signaling pathways;Abdelsalam;J. Neurochem.,2015

3. The effect of docosahexaenoic acid on apelin distribution of nervous system in the experimental mouse model of Parkinson’s disease;Acar;Tissue Cell,2019

4. Carvedilol induces the antiapoptotic proteins Nrf2 and Bcl2 and inhibits cellular apoptosis in aluminum-induced testicular toxicity in male Wistar rats;Ahmed;Biomed. Pharmacother.,2021

5. Methyl jasmonate abrogates rotenone-induced parkinsonian-like symptoms through inhibition of oxidative stress, release of pro-inflammatory cytokines, and down-regulation of immnopositive cells of NF-κB and α-synuclein expressions in mice;Alabi;Neurotoxicology,2019

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system;Translational Neurodegeneration;2024-08-09

2. Crosstalk between gut–brain axis: unveiling the mysteries of gut ROS in progression of Parkinson’s disease;Inflammopharmacology;2024-07-11

3. Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus;Medicina Clínica;2024-07

4. Sodium‐glucose cotransporter 1/2 inhibition and risk of neurodegenerative disorders: A Mendelian randomization study;Brain and Behavior;2024-07

5. Effect of empagliflozin in peripheral diabetic neuropathy of patients with type 2 diabetes mellitus;Medicina Clínica (English Edition);2024-07